Improving Treatment for Pediatric Cardiomyopathy

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Rakesh Singh, MD, MS, discussed some of these new developments in treatment during the 2014 American Heart Association Scientific Sessions in Chicago.